Ahmed Alomari
Has grant
Assistant Professor and Dermatopathologist
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
About
Ahmed Alomari is an Assistant Professor and Dermatopathologist at the Indiana University School of Medicine in the United States. His research areas encompass dermatopathology, with a particular focus on melanocytic tumors, immune evasion in melanoma, and the genomic characterization of neoplasms. Recent articles authored by Dr. Alomari include studies on cutaneous neoplasms and their molecular signatures, reflecting his expertise in the intersection of histopathology and molecular biology.
Recent Grants
Grant: Close
AI-based characterization of the tumor microenvironment of melanoma
Open Date: 2021-08-01
Close Date: 2023-12-01
Grant: Close
Evaluation of hyaluronan expression and inflammatory milieu in various histologic and molecular subtypes of melanoma.
Open Date: 2021-01-01
Close Date: 2022-12-01
Articles (31)
Year:
2026
Year:
2026
Year:
2026
To date our knowledge of the genomic landscape of cellular neurothekeoma (cNTK) remains incomplete. Thus, in order to comprehensively elucidate the mutational profile of this rare tumour type and identify driver events, we sequenced DNA (whole-exome sequencing) and RNA (pulldown transcriptome) from an international, multi-institutional cohort of cNTK tumour-normal pairs (n = 20). We identified copy number (CN) alterations as a driver event of this tumour type, with the most recurrent CN alteration being a deletion on 9p21.3 that encompassed MTAP and the C-terminal exons of CDKN2A.
Year:
2026
Introduction Organizing pneumonia (OP) is often considered a benign finding, but in some cases, it may be associated with underlying malignancy. With the increasing use of minimally invasive biopsy techniques, understanding the relationship between OP and lung cancer is critical to avoid delayed or missed diagnoses. This study aims to evaluate the prevalence of OP and lung malignancy and report characteristics of these cases. Material and methods A retrospective review was conducted of all lung pathology reports at Indiana University from January 1, 2010, to January 1, 2023, encompassing over 8,000 cases. Cases with histopathologic diagnoses of OP with and without lung malignancy were identified; relevant clinical, radiologic, and follow-up data were extracted. Using language extraction, we identified pathology cases showing both organizing pneumonia and carcinoma (Cohort 1) and transbronchial biopsies identified as “organizing pneumonia” (Cohort 2). Cohort 2 was selected to reflect current clinical practice. Results In Cohort 1 (n=57), 88% of samples demonstrating both organizing pneumonia and malignancy were obtained via surgical resection. Among these, squamous cell carcinoma accounted for 46% and adenocarcinoma for 37% of cases, with all T-stages represented (44% T1, 29% T2, 16% T3, and 11% T4). In this cohort, thirty-eight prior biopsy samples prior to surgery were reviewed; 76% revealed malignancy, but none showed definitive organizing pneumonia likely due to focal nature of OP. Cohort 2 (n=40), 7.5% of patients in whom organizing pneumonia was identified through minimally invasive bronchoscopic sampling were ultimately diagnosed with concurrent lung cancer. All required repeat tissue sampling for cancer diagnosis. Conclusion Lung malignancy is known to be associated with OP. A high degree of suspicion should be maintained if OP is found on minimally invasive techniques, particularly if malignancy is strongly suspected.
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Langerhans cell sarcoma (LCS) is a rare neoplastic proliferation of Langerhans cell with aggressive clinical behavior and involves multiple organ systems, including the skin. LCS is characterized by marked cytologic atypia, frequent mitoses including atypical ones, and expression of CD1a, S100, and langerin (CD207). CD1a and Langerin‐positive but S100− negative LCS is extremely rare in clinical practice. We present a case of a 71‐year‐old female with a history of melanoma and atypical fibroxanthoma who presented with an erythematous plaque on her left knee. Histopathologic examination revealed a dermal infiltrate comprised of large pleomorphic cells with irregular nuclear contours, prominent longitudinal grooves, and vesicular chromatin, and a high mitotic rate. Notably, there were epidermotropism and a distinctive immunohistochemical profile: S100−, CD1a+, Langerin+, and focal CD68+. Next‐generation sequencing identified copy number loss of CDKN2A , CDKN2B , and FOXA1 , mutations in TP53 , POT1 , SH2B3 , and SMARCA4 , and a high tumor mutational burden. Herein, we discuss the clinical and pathologic features of 38 cases of LCS with cutaneous involvement reported in the literature, including recent advances in understanding molecular characteristics of this disease. This exceptional case may contribute to our understanding of the etiology of this rare neoplasm.
Year:
2025
Microsatellites in melanoma are physically separate from the primary tumor, are hypothesized to arise by lymphovascular invasion similar to other metastases, and have not been previously studied at the molecular level . We compared gene expression in microsatellites with the matched primary melanoma in two patients using spatial transcriptomics. We identified recurrently altered genes in microsatellites contributing to vascular invasion (ITGA4, MCAM), survival in the circulation (CXCL8, PDGFRB, CDH1), vascular exit (ITGB2), survival at metastatic sites (C3, TGBFI), matrix remodeling (MMP9, VCAN, FN1, BGN), and angiogenesis (EMILIN2). Gene set enrichment analysis confirmed a metastatic signature in comparison to genes upregulated and downregulated in distant melanoma metastases, and identified pathway enrichment for NFKB, CDH1, and ZEB1 signaling. Microsatellites exhibited increased host immune responses and four recurrently overexpressed mediators of immune evasion were present (PAEP, GDF15, CD74, HLA-DRA) implying selection pressure from the increased immune response. Seven additional non-recurrent mediators of immune evasion were identified in microsatellites, overexpressed up to 58-fold in microsatellites. PAEP was 275-fold and 25-fold overexpressed, respectively, in microsatellites in two cases. We studied PAEP protein expression by immunohistochemistry in a larger group of 12 and found overexpression in microsatellites in five of 12 patients. PAEP was detected by immunohistochemistry in a microsatellite and also in a subclone within its primary, raising the possibility that the immunostain identifies the subclone in the primary responsible for the microsatellite. These preliminary findings suggest that melanoma microsatellites are true metastases at the level of gene expression, accounting for the sharply increased risk of disease progression in patients with microsatellites.
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Collaborators (21)
Catherine Sears
Associate Professor
-
Franck Tirode
Directeur de recherche 2
INSERM
Rachel Kowal
Assistant Professoor
Indiana University School of Medicine
Ying S. Zou
Johns Hopkins University
Shaofeng Yan
-
Chao Chen
Assistant Professor
Stony Brook University
Lei Wei
Assistant Professor
Roswell Park Comprehensive Cancer Center
Carolin Mogler
Acting director
Technical University of Munich
Matthew Vesely
Assistant Professor
Yale University School of Medicine
S. J. Warren
Professor
University of Michigan
Kun Huang
Professor and Chair
Indiana University School of Medicine
Peter M. Ferguson
Melanoma Institute Australia
David Adams
Senior Group Leader (and Interim Programme Head)
Wellcome Sanger Institute
RAVINDRA KOLHE
Augusta University
Matthew Kuhar
Indiana University Bloomington
Joel Lefferts
Dartmouth-Hitchcock Medical Center
Ingrid FERREIRA
Cliniques Universitaires Saint-Luc
Kristen Deak
Assistant Professor
Duke University
Cynthia Reyes Barron
Non-salaried faculty, Clinical Assistant Professor
Texas Tech University Health Sciences Center El Paso Paul L Foster School of Medicine
Richard A. Scolyer
Faculty Member
University of Sydney
Jean-Yves Scoazec
Université Paris-Saclay
Make your next move.
Prepare your application
Review drafts before you send them.